Skip to main content
Fig. 2 | Journal of Nanobiotechnology

Fig. 2

From: Dual-targeting tigecycline nanoparticles for treating intracranial infections caused by multidrug-resistant Acinetobacter baumannii

Fig. 2

Characterization of Aβ11/T80@CSs. A The size distribution of Aβ11/T80@CSs was analyzed. B Zeta potential measurements were conducted to assess the surface charge of Aβ11/T80@CSs. C The Tyndall effect was employed to characterize the appearance and colloidal nature of Aβ11/T80@CSs. D Transmission Electron Microscopy (TEM) was used to visualize the structural morphology of Aβ11/T80@CSs. E The storage stability of Aβ11/T80@CSs at 4 °C was evaluated by measuring particle size and encapsulation efficiency on days 0, 1, 3, 5, and 7. F The release profile of Aβ11/T80@CSs in phosphate-buffered saline (PBS) was investigated using a dynamic dialysis method. All data are expressed as the mean ± standard deviation (SD), based on n = 3 independent experiments

Back to article page